Hangzhou Biotest Biotech Co.,Ltd. (SHA:688767)
China flag China · Delayed Price · Currency is CNY
44.85
+0.41 (0.92%)
May 30, 2025, 2:45 PM CST

Hangzhou Biotest Biotech Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2017 - 2019
Period Ending
May '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2017 - 2019
Market Capitalization
4,6613,4523,2294,9287,456-
Upgrade
Market Cap Growth
48.09%6.92%-34.48%-33.91%--
Upgrade
Enterprise Value
3,0371,8451,3702,7745,736-
Upgrade
Last Close Price
44.6032.5228.9141.0759.58-
Upgrade
PE Ratio
34.2720.3630.296.378.94-
Upgrade
PS Ratio
9.116.177.302.594.10-
Upgrade
PB Ratio
1.921.431.331.923.54-
Upgrade
P/TBV Ratio
2.171.621.462.103.57-
Upgrade
P/FCF Ratio
357.59-43.089.4010.53-
Upgrade
P/OCF Ratio
46.6726.8024.587.018.21-
Upgrade
EV/Sales Ratio
5.943.303.101.463.16-
Upgrade
EV/EBITDA Ratio
28.8013.7747.443.595.92-
Upgrade
EV/EBIT Ratio
36.2916.36325.743.695.97-
Upgrade
EV/FCF Ratio
232.96-18.285.298.10-
Upgrade
Debt / Equity Ratio
000.000.000.010.03
Upgrade
Debt / EBITDA Ratio
0.010.000.090.010.010.02
Upgrade
Debt / FCF Ratio
0.08-0.040.020.020.03
Upgrade
Asset Turnover
0.200.220.170.731.192.05
Upgrade
Inventory Turnover
3.313.322.306.796.033.77
Upgrade
Quick Ratio
15.609.8113.2712.165.931.93
Upgrade
Current Ratio
16.7410.5113.9713.076.402.46
Upgrade
Return on Equity (ROE)
5.57%6.90%4.23%33.13%65.52%152.90%
Upgrade
Return on Assets (ROA)
2.04%2.72%0.10%18.15%39.19%77.90%
Upgrade
Return on Capital (ROIC)
2.16%2.91%0.10%20.06%46.66%107.44%
Upgrade
Return on Capital Employed (ROCE)
3.40%4.70%0.20%29.20%45.50%118.70%
Upgrade
Earnings Yield
2.97%4.91%3.30%15.70%11.18%-
Upgrade
FCF Yield
0.28%-3.37%2.32%10.64%9.50%-
Upgrade
Dividend Yield
3.36%4.61%2.77%5.36%5.04%-
Upgrade
Payout Ratio
98.73%49.34%220.13%41.37%2.51%23.07%
Upgrade
Buyback Yield / Dilution
-0.82%1.23%0.10%-23.15%-8.33%0.01%
Upgrade
Total Shareholder Return
2.55%5.85%2.86%-17.79%-3.29%0.01%
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.